Byrne BJ - Search Results

1

Targeted approaches to induce immune tolerance for Pompe disease therapy.

Doerfler PA, Nayak S, Corti M, Morel L, Herzog RW, Byrne BJ. Doerfler PA, et al. Among authors: byrne bj. Mol Ther Methods Clin Dev. 2016 Jan 27;3:15053. doi: 10.1038/mtm.2015.53. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 26858964 Free PMC article. Review.

2

Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors.

Fraites TJ Jr, Schleissing MR, Shanely RA, Walter GA, Cloutier DA, Zolotukhin I, Pauly DF, Raben N, Plotz PH, Powers SK, Kessler PD, Byrne BJ. Fraites TJ Jr, et al. Among authors: byrne bj. Mol Ther. 2002 May;5(5 Pt 1):571-8. doi: 10.1006/mthe.2002.0580. Mol Ther. 2002. PMID: 11991748 Free article.

3

Improved method of recombinant AAV2 delivery for systemic targeted gene therapy.

Mah C, Fraites TJ Jr, Zolotukhin I, Song S, Flotte TR, Dobson J, Batich C, Byrne BJ. Mah C, et al. Among authors: byrne bj. Mol Ther. 2002 Jul;6(1):106-12. doi: 10.1006/mthe.2001.0636. Mol Ther. 2002. PMID: 12095310 Free article.

4

Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity.

Martino AT, Nayak S, Hoffman BE, Cooper M, Liao G, Markusic DM, Byrne BJ, Terhorst C, Herzog RW. Martino AT, et al. Among authors: byrne bj. PLoS One. 2009 Aug 4;4(8):e6376. doi: 10.1371/journal.pone.0006376. PLoS One. 2009. PMID: 19652717 Free PMC article.

5

Pompe disease gene therapy.

Byrne BJ, Falk DJ, Pacak CA, Nayak S, Herzog RW, Elder ME, Collins SW, Conlon TJ, Clement N, Cleaver BD, Cloutier DA, Porvasnik SL, Islam S, Elmallah MK, Martin A, Smith BK, Fuller DD, Lawson LA, Mah CS. Byrne BJ, et al. Hum Mol Genet. 2011 Apr 15;20(R1):R61-8. doi: 10.1093/hmg/ddr174. Epub 2011 Apr 25. Hum Mol Genet. 2011. PMID: 21518733 Free PMC article. Review.

6

Spinal delivery of AAV vector restores enzyme activity and increases ventilation in Pompe mice.

Qiu K, Falk DJ, Reier PJ, Byrne BJ, Fuller DD. Qiu K, et al. Among authors: byrne bj. Mol Ther. 2012 Jan;20(1):21-7. doi: 10.1038/mt.2011.214. Epub 2011 Oct 18. Mol Ther. 2012. PMID: 22008916 Free PMC article.

7

Prevention and Reversal of Antibody Responses Against Factor IX in Gene Therapy for Hemophilia B.

Nayak S, Sarkar D, Perrin GQ, Moghimi B, Hoffman BE, Zhou S, Byrne BJ, Herzog RW. Nayak S, et al. Among authors: byrne bj. Front Microbiol. 2011 Dec 7;2:244. doi: 10.3389/fmicb.2011.00244. eCollection 2011. Front Microbiol. 2011. PMID: 22279442 Free PMC article.

8

Mapping the T helper cell response to acid α-glucosidase in Pompe mice.

Nayak S, Sivakumar R, Cao O, Daniell H, Byrne BJ, Herzog RW. Nayak S, et al. Among authors: byrne bj. Mol Genet Metab. 2012 Jun;106(2):189-95. doi: 10.1016/j.ymgme.2012.03.009. Epub 2012 Mar 23. Mol Genet Metab. 2012. PMID: 22494547 Free PMC article.

9

Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy.

Sack BK, Merchant S, Markusic DM, Nathwani AC, Davidoff AM, Byrne BJ, Herzog RW. Sack BK, et al. Among authors: byrne bj. PLoS One. 2012;7(5):e37671. doi: 10.1371/journal.pone.0037671. Epub 2012 May 24. PLoS One. 2012. PMID: 22655063 Free PMC article.

10

Gene therapy approaches for lysosomal storage disease: next-generation treatment.

Byrne BJ, Falk DJ, Clément N, Mah CS. Byrne BJ, et al. Hum Gene Ther. 2012 Aug;23(8):808-15. doi: 10.1089/hum.2012.140. Hum Gene Ther. 2012. PMID: 22794786 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters